Delivery Order SPE2DB24D9802-SPE2DB25FJLCB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,801.55 to DMS Pharmaceutical Group Inc. for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, was executed without a set-aside designation. The award represents a standard transactional order under DMS Pharmaceutical Group's broader pharmaceutical supply contract with DLA, fulfilling the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $4,947.96 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine. The contract, which carries an ultimate completion date of August 15, 2025, was issued without a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,441.24 by the Defense Logistics Agency on July 30, 2025. The delivery order is for MENVEO A-C-Y-W Kit (2 Vials), a meningococcal vaccine product, with an ultimate completion date of July 31, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal...
- This is a $1,080.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the MENVEO VACCINE VL 5S medical product, with an ultimate completion date of June 17, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a $6,236.64 firm fixed price delivery order to supply one vial of MENVEO, a meningococcal vaccine. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with Defense Logistics Agency to provide various pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS...
- This $27,477.72 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,522.17 for MENVEO Vaccine VL 5S under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program. The award is firm fixed price with no set-aside designation, and the ultimate completion date is July 31, 2025. This delivery order represents one of numerous pharmaceutical product orders issued under DMS Pharmaceutical...
- This delivery order awards $2,075.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine product. The Defense Logistics Agency issued this firm fixed-price delivery order on July 25, 2025, with an ultimate completion date of July 28, 2025. The award carries no set-aside designation, and performance will occur at the contractor's Park Ridge, Illinois location. This...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,676.34, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of May 8, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the MENVEO vaccine, a meningococcal vaccine, over a period ending on May 29, 2025. The total ceiling value of the contract is $131,873.46. DMS Pharmaceutical Group Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB25FJLCBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,151.64 to DMS Pharmaceutical Group Inc. for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed in Park Ridge, Illinois, the vendor's headquarters location. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this engagement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC establishes the company as a key supplier for pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has maintained consistent success in federal pharmaceutical procurement since its registration in SAM.gov in 2001, leveraging its woman-owned small business status to compete effectively while providing essential medical supplies and medications to military healthcare systems across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/18/25 |